Dr. Alfred L Garfall | CureTalks
Dr. Alfred L. Garfall is Director of Autologous Hematopoietic Stem Cell Transplantation and Assistant Professor of Medicine at the Hospital of the University of Pennsylvania. He is board certified in Hematology, Internal Medicine and Medical Oncology and is a part of various programs such as Amyloidosis Program, Bone Marrow and Stem Cell Transplant Program, Hematological Malignancies (Blood Cancer) Program and Multiple Myeloma Program at Penn Medicine. His research focuses on immunotherapy, translational research and clinical trials. Dr. Garfall received his medical degree from New York University School of Medicine and completed his residency from Brigham and Women's Hospital.
U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for teclistamab in the treatment of relapsed or refractory multiple myeloma.…